The Lowering the Cost of Prescription Drugs Act of 2026 (B 26-0593) authorizes the Mayor to partner with ArrayRX, a multi-state prescription drug discount program, to create a citywide drug discount card program for all District residents. This program would provide access to lower-cost prescription drugs regardless of insurance status (public, private, or none), expanding beyond existing targeted laws like the Insulin Affordability Act. The key mechanism is a cooperative purchasing agreement that leverages collective buying power to secure deeper discounts than individual consumers could achieve. It directly affects all DC residents facing high drug costs, aiming to reduce out-of-pocket expenses for medications. The bill does not alter insurance coverage but creates a new access point through this partnership.
This procedural resolution (PR 26-0106) approves Contract Modifications Nos. 8 and 9 for a pharmacy benefit management system under Contract No. CW94739 with Ramsell Corporation, authorizing payment for services provided from January 2025 through January 2026. It specifically exercises the remaining third option year of the contract, increasing the total value from $998,000 to $10,500,000. The resolution declares an emergency to expedite Council approval under DC Home Rule Act requirements, ensuring Ramsell Corporation can be paid for vital health services without disruption.
This bill approves Modifications 8 and 9 to an existing contract with Ramsell Corporation for a pharmacy benefit management system (PBMS) and authorizes $10.5 million in payments. It directly affects DC Health programs serving HIV patients, including the AIDS Drug Assistance Program (ADAP), PrEP/PEP, and Medication Assisted Therapy, which provide prescription coverage for uninsured or underinsured District residents. The key provision extends the contract for option year three (2025-2026), covering medication management, insurance premium assistance, and data reporting for these health programs. The funding ensures continued access to critical medications and support services without adding new policy requirements.
The Community Health Amendment Act of 2025 allows pharmacists and pharmacy technicians in Washington, D.C., to order and administer vaccines without a prescription, directly affecting residents, visitors, and workers who receive vaccinations at pharmacies. It replaces the requirement to follow only CDC guidelines with a provision permitting vaccines based on guidelines from CDC or any "competent medical or public health organization" designated by D.C. Health through public notice. This permanently codifies emergency measures approved in September 2025 that temporarily expanded vaccine access during federal uncertainty. The bill does not address insurance coverage, which remains covered under separate insurance guidelines.
This resolution declares a health emergency to allow pharmacists and pharmacy technicians in Washington, D.C. to administer recommended vaccines (for respiratory illnesses like flu, RSV, and COVID-19) without a prescription during the 2025-2026 respiratory season. It directly affects pharmacists, pharmacy technicians, and residents (including minors under 18) by removing a current legal barrier tied to federal policy changes. The key mechanism amends two existing laws - the Health Occupations Revision Act of 1985 and the Consent for Vaccinations of Minors Amendment Act of 2022 - to align with prior seasons when pharmacists could independently provide these immunizations. The resolution takes effect immediately to prevent pharmacy closures of vaccine services during the upcoming respiratory disease surge.
